GLIX yields 1.68% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GLIX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLIX + PFE for your $10,000?
GLIX seeks to generate alpha from the long-term growth trends of global infrastructure development and modernization. The fund primarily invests in large-cap companies that derive over 50% of their revenues or assets from infrastructure activities. These activities include water treatment, generation and distribution of energy and resources, communication and media services, as well as the development or operation of infrastructure such as pipelines, roads, airports, railroads, and ports. Security selection focuses on monopolistic businesses that deliver stable long-term cash flows with inflation-linked revenues and lower volatility than the broader equity market. The portfolio consists of 25-50 preferred infrastructure companies. GLIX offers global diversification, including exposure to emerging markets. Currency risk is hedged through foreign currency forward contracts to reduce volatility against the US dollar. The fund may also utilize repurchase agreements and money market instruments.
Full GLIX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.